Arbutus Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABUS and other ETFs, options, and stocks.About ABUS
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV).
ABUS Key Statistics
Stock Snapshot
With a market cap of 1B, Arbutus Biopharma(ABUS) trades at $5.04. The stock has a price-to-earnings ratio of 6.47.
On 2026-08-29, Arbutus Biopharma(ABUS) stock moved within a range of $5.04 to $5.19. With shares now at $5.04, the stock is trading 0.0% above its intraday low and -2.8% below the session's peak.
Trading volume for Arbutus Biopharma(ABUS) stock has reached 4.77M, versus its average volume of 6.56M.
The stock's 52-week range extends from a low of $3.50 to a high of $5.45.
The stock's 52-week range extends from a low of $3.50 to a high of $5.45.
ABUS News
Arbutus Biopharma (ABUS) has drawn investor attention after launching a modified Dutch Auction tender offer of up to US$230 million in stock repurchases, signal...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
Arbutus Biopharma (ABUS) announced the commencement of a modified Dutch Auction tender offer to purchase for cancellation up to $230M in value of its common sha...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.